Literature DB >> 18196743

Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs.

Joan R Coates1, Philip A March, Michael Oglesbee, Craig G Ruaux, Natasha J Olby, Roy D Berghaus, Dennis P O'Brien, John H Keating, Gary S Johnson, David A Williams.   

Abstract

BACKGROUND: Adult dogs with degenerative myelopathy (DM) have progressive ataxia and paresis of the pelvic limbs, leading to paraplegia and euthanasia. Although most commonly reported in German Shepherd dogs, high disease prevalence exists in other breeds.
OBJECTIVE: Our aim was the clinical and histopathologic characterization of familial degenerative myelopathy (FDM) in Pembroke Welsh Corgi (PWC) dogs. ANIMALS: Twenty-one PWCs were prospectively studied from initial diagnosis until euthanasia.
METHODS: Neurologic examination, blood tests, cerebrospinal fluid (CSF) analysis, electrodiagnostic testing, and spinal imaging were performed. Concentrations of 8-iso-prostaglandin F2alpha (8-isoprostane) were measured in CSF. Routine histochemistry was used for neuropathology. Deoxyribonucleic acid and pedigrees were collected from 110 dogs.
RESULTS: Median duration of clinical signs before euthanasia was 19 months. Median age at euthanasia was 13 years. All dogs were nonambulatory paraparetic or paraplegic, and 15 dogs had thoracic limb weakness at euthanasia. Electrodiagnostic testing and spinal imaging were consistent with noncompressive myelopathy. No significant difference was detected in 8-isoprostane concentrations between normal and FDM-affected dogs. Axonal and myelin degeneration of the spinal cord was most severe in the dorsal portion of the lateral funiculus. Pedigree analysis suggested a familial disease. CONCLUSIONS AND CLINICAL IMPORTANCE: Clinical progression of FDM in PWC dogs was similar to that observed in other breeds but characterized by a longer duration. Spinal cord pathology predominates as noninflammatory axonal degeneration. Oxidative stress injury associated with 8-isoprostane production is not involved in the pathogenesis of FDM-affected PWC dogs. A familial disease is suspected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18196743     DOI: 10.1892/07-059.1

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  18 in total

1.  Genome-wide association studies for multiple diseases of the German Shepherd Dog.

Authors:  Kate L Tsai; Rooksana E Noorai; Alison N Starr-Moss; Pascale Quignon; Caitlin J Rinz; Elaine A Ostrander; Jörg M Steiner; Keith E Murphy; Leigh Anne Clark
Journal:  Mamm Genome       Date:  2011-11-22       Impact factor: 2.957

2.  Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate.

Authors:  Shinichiro Maki; Md Shafiqul Islam; Tomohito Itoh; Masanobu Nurimoto; Akira Yabuki; Yu Furusawa; Hiroaki Kamishina; Yui Kobatake; Tofazzal Md Rakib; Martia Rani Tacharina; Osamu Yamato
Journal:  Animals (Basel)       Date:  2022-06-27       Impact factor: 3.231

3.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

4.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

5.  Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model.

Authors:  Matthew J Crisp; Jeffrey Beckett; Joan R Coates; Timothy M Miller
Journal:  Exp Neurol       Date:  2013-05-23       Impact factor: 5.330

6.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

7.  Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; G Diane Shelton; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-12-21       Impact factor: 4.164

Review 8.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

9.  A retrospective study of the prevalence of the canine degenerative myelopathy associated superoxide dismutase 1 mutation (SOD1:c.118G > A) in a referral population of German Shepherd dogs from the UK.

Authors:  Angela L Holder; James A Price; Jamie P Adams; Holger A Volk; Brian Catchpole
Journal:  Canine Genet Epidemiol       Date:  2014-09-25

10.  Breed distribution of SOD1 alleles previously associated with canine degenerative myelopathy.

Authors:  R Zeng; J R Coates; G C Johnson; L Hansen; T Awano; A Kolicheski; E Ivansson; M Perloski; K Lindblad-Toh; D P O'Brien; J Guo; M L Katz; G S Johnson
Journal:  J Vet Intern Med       Date:  2014-02-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.